Home / Caregiver & Patient / Wilson’s Disease

Diseases

Click here to view more Diseases

Wilson’s Disease

Wilson's disease is a rare genetic disorder caused by a mutation in the ATP7B gene, affecting the liver's ability to eliminate excess copper from the body. As a result, copper builds up and damages vital organs, such as the liver and brain. While Wilson's disease is rare, it is more prevalent in certain regions, including India.

Symptoms

The symptoms of Wilson's disease can vary widely among individuals. Some common signs and symptoms include:

  • Jaundice: Yellowing of the skin and eyes due to liver dysfunction.
  • Hepatic Symptoms: Fatigue, abdominal pain, and liver enlargement.
  • Neurological Symptoms: Tremors, difficulty speaking or swallowing, uncontrolled movements, and personality changes.
  • Kayser-Fleischer Rings: A golden-brown discoloration around the iris of the eye, caused by copper deposits.
  • Psychological Symptoms: Depression, anxiety, and cognitive changes.
Diagnosis

Diagnosing Wilson's disease requires a combination of clinical evaluation, laboratory tests, and genetic analysis. The following diagnostic procedures are commonly used:

  • Blood and Urine Tests: These tests measure copper levels in the blood and urine, as well as other liver function markers.
  • Liver Biopsy: A small sample of liver tissue is taken for examination to assess copper accumulation and liver damage.
  • Genetic Testing: DNA analysis is conducted to identify mutations in the ATP7B gene.
Treatment

Wilson's disease is a lifelong condition, but effective treatments are available. The primary goal of treatment is to lower copper levels in the body and prevent its accumulation in organs. Treatment options include:

  • Medications: Copper-chelating agents, such as D-penicillamine and trientine, help remove excess copper from the body.
  • Zinc: This is also another medication that decreases the copper deposition in the body by limiting copper absorption from the food in the intestine.
  • Liver Transplantation: In severe cases where liver damage is extensive, a liver transplant may be necessary.
Support and Management

Living with Wilson's disease requires long-term management and monitoring. It is essential to follow these guidelines:

  • Regular Medical Check-ups: Schedule regular follow-up appointments with a hepatologist or gastroenterologist experienced in Wilson's disease.
  • Medication Compliance: Take prescribed medications as directed by the doctor.
  • Dietary Modifications: Follow a low-copper diet, avoiding foods rich in copper, such as shellfish, nuts, and chocolate.
  • Family Screening: Relatives of a person diagnosed with Wilson's disease should undergo genetic testing to identify potential carriers.

Frequently Asked Questions

Wilson's disease is a rare genetic disorder that affects the body's ability to metabolize copper. As a result, copper builds up in the liver and other organs, causing damage over time.

The symptoms of Wilson's disease can vary widely. Some common symptoms include fatigue, jaundice (yellowing of the skin and eyes), abdominal pain, tremors, difficulty speaking or swallowing, muscle stiffness, and behavioral changes.

Wilson's disease can be challenging to diagnose because its symptoms overlap with those of other conditions. Doctors typically perform a combination of blood tests to measure copper levels, liver function tests, and genetic testing to confirm the diagnosis. Additional tests, such as a liver biopsy or imaging scans, may be necessary in some cases.

Yes, Wilson's disease is treatable. The primary treatment involves lifelong administration of medications called copper chelators, which help remove excess copper from the body. Medications such as penicillamine, trientine, and zinc acetate are commonly used for this purpose. In some cases, liver transplantation may be necessary if the liver becomes severely damaged.

While there is no known cure for Wilson's disease, with appropriate treatment and management, the condition can be effectively controlled. Adhering to the prescribed treatment plan, including taking medications and following dietary recommendations, is crucial for long-term management.

Yes, Wilson's disease is an inherited disorder caused by a mutation in the ATP7B gene. It follows an autosomal recessive pattern, which means that both parents must carry a copy of the mutated gene for their child to develop the disease. If both parents are carriers, each child has a 25% chance of inheriting the condition.

The symptoms and progression of Wilson's disease can vary between children and adults. Children often experience liver-related symptoms, such as hepatomegaly (enlarged liver) and jaundice, while adults may present with neurological symptoms, such as tremors and difficulty with movement. However, both age groups can exhibit a combination of liver and neurological symptoms.

In general, a well-balanced diet is recommended for individuals with Wilson's disease. However, certain foods that are high in copper should be avoided or limited. These include organ meats, shellfish, nuts, chocolate, and mushrooms. It's important to consult with a doctor or registered dietitian to create a personalized diet plan.

Individuals with Wilson's disease can have children, but there is a risk of passing the condition on to their offspring. Genetic counseling is recommended to assess the likelihood of transmitting the disease and discuss options for family planning.

Yes, Wilson's disease can be misdiagnosed because its symptoms can mimic those of other conditions, such as hepatitis, Parkinson's disease, or psychiatric disorders. That's why it's important to consult with a specialist, such as a hepatologist or neurologist, who has experience in diagnosing and treating Wilson's disease.

If left untreated or poorly managed, Wilson's disease can lead to severe complications. Copper accumulation can cause liver damage, leading to cirrhosis, liver failure, or hepatocellular carcinoma. Neurological symptoms such as tremors, dystonia, and difficulty with coordination can also occur. Proper treatment and monitoring help minimize these long-term effects.

Yes, individuals with Wilson's disease can typically go to school and work, although it may depend on the severity of their symptoms and the specific demands of their work or education. With appropriate treatment and management, most individuals with Wilson's disease can lead normal lives and engage in educational and work-related activities.

Consuming alcohol is known to accelerate and exacerbate the effects of Wilson's disease, making it advisable to refrain from drinking. If you have cirrhosis, it is highly recommended to abstain from alcohol entirely for your well-being.

Wilson's disease itself does not directly make individuals more prone to infections. However, certain factors associated with the disease or its treatment can potentially increase the risk of infections. It is important for individuals with Wilson's disease to take precautions to minimize the risk of infections. This includes practicing good hygiene, maintaining a balanced and nutritious diet, staying up to date with vaccinations, and following their doctor's recommendations regarding treatment and monitoring of the disease. Regular medical follow-up is crucial to monitor liver function and overall health.

Wilson's disease is a genetic disease (Inherited autosomal recessive), which means that both parents must have the mutation and give it to a child for the child to have the disease. It's not contagious.

References

  • Ferenci P, Członkowska A, Merle U, et al. Wilson disease. Nat Rev Dis Primers. 2019;5(1):21.
  • Roberts EA, Schilsky ML; American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47(6):2089-2111.
  • Aggarwal A, Choudhury A, Goel A, et al. Wilson's disease: a clinical and genetic study in 55 Indian patients. Movement Disorders. 2008;23(5):724-731.
  • European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol. 2012 Jun;56(3):671-85.
  • Ferenci P, Członkowska A, Merle U, et al. Late-onset Wilson's disease. Gastroenterology. 2007;132(4):1294-98.
  • Brewer GJ, Askari F, Lorincz MT, et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol. 2006;63(4):521-27.